--- Query Results --- | |||
| Organization: | Alberta Precision Laboratories | ||
| Test Name/Synonym: | High Sensitivity Neurofilament, Light Chain (Referred Test AI) (Synonyms: LDT, PNF-L) | ||
| Clinical Indications: | Multiple Sclerosis: concentrations of neurofilament light chain correlate with disease severity and prognosis. Circulating neurofilament is a useful biomarker for monitoring disease activity and treatment response. ALS: neurofilament light chain may be a useful biomarker to assess effectiveness of some ALS therapies. | ||
| Ordering Alert: | Due to a lack of specificity to a particular neurodegenerative disease, this test should NOT be used as a diagnostic marker. Restricted to MS and ALS neurologists. Note to ordering physician: This test will be reviewed for approval by Laboratory Medical or Scientific staff. | ||
| LABID (Connect Care): | LAB11064 | ||
| Specimen Type: | Blood | ||
| Primary Container: | GOLD SST | ||
| Specimen Collection Requirements: | Refer to the Mitogen Autoantibody Test Requisition at https://mitogendx.com/requisition-forms/ | ||
| Test Resources: |
| ||
| Transportation: | For testing sent to Calgary External Send Outs: transport refrigerated. For testing sent to Edmonton External Send Outs: transport frozen. | ||
| Testing Area: | Referred Out | ||
| Performing Site: | Testing referred out to Mitogen Dx | ||
| Additional Test Information: | Concentrations of neurofilament in plasma have been shown to be approximately 5% to 10% lower than those measured in serum. | ||
| Last Updated On: | Thursday, February 6, 2025 | ||
